Stock research
LRMR Larimar Therapeutics, Inc.
Healthcare • Biotechnology
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive...…
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
ALL change
-60.29%
Range high
$15.11
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in LRMR?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $3.98
- Day High
- $4.14
- Day Low
- $3.82
- 52w High
- $6.42
- 52w Low
- $2.72
- Volume
- 1,679,942
- Avg Volume
- Beta
- 0.75
* TTM/most recent where available
Company
- Ticker
- LRMR
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Carole S. Ben-Maimon
- Employees
- 71
- Website
- www.larimartx.com
Key Metrics
- Market Cap
- 427M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).